Wednesday 18 March 2020
Tuesday 17 March 2020
Investorideas.com - Cannabis Stock News: Canopy Growth (TSX: $WEED.TO) (NYSE: $CGC) to temporarily close corporate owned retail amid response to COVID-19
Investorideas.com - Cannabis Stock News: Canopy Growth (TSX: $WEED.TO) (NYSE: $CGC) to temporarily close corporate owned retail amid response to COVID-19
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 384- Cannabis #Coronavirus Closures (TSX: $WEED.TO)(NYSE: $CGC), (TSXV: $LIFT.V) (OTCQB: $LFCOF)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 384- Cannabis #Coronavirus
Closures (TSX: $WEED.TO)(NYSE: $CGC), (TSXV: $LIFT.V) (OTCQB: $LFCOF)
Delta, Kelowna, BC, March 17th, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/03171WEED-CGC-LIFT-LFCOF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few company announcements.
Canopy Growth
Corporation (TSX:
WEED)(NYSE: CGC) has been monitoring the COVID-19
outbreak and paying close attention to the guidance given by public health
bodies around the globe. Canopy Growth's leadership team has
made the decision to temporarily close all corporate-owned
Tokyo Smoke and Tweed retail locations across Canada, effective at 5:00 p.m.
local time today, March 17.
"We
have a responsibility to our employees, their families, and our communities to
do our part to "flatten the curve" by limiting social interactions.
For us, that means shifting our focus from retail to e-commerce," said
David Klein, CEO, Canopy Growth. "This is a big decision but it was also
an easy one to make – our retail teams are public-facing and have been serving
an above-average volume of transactions in recent days. Given the current
situation, it is in the best interest of our teams and our communities to close
these busy hubs until we are confident we can operate our stores in the best
interest of public health."
Canopy
Growth also has a responsibility to its customers and medical patients to
continue providing access to their desired cannabis products and prescribed
medication. The Company has established, fully supported e-commerce platforms
available to our recreational and medical customers across the country to
provide business continuity for people seeking our products.
The
decision affects the 23 corporately-owned stores in Newfoundland, Saskatchewan,
and Manitoba as well as the Tweed Visitor Centre in Smiths Falls, ON.
Patients
will be able to continue purchasing medical cannabis through Spectrum
Therapeutics. Adult consumers
within Manitoba and Saskatchewan are able to purchase Canopy Growth products
through Tweed and Tokyo
Smoke e-commerce
platforms, all other provinces and territories will be supported through
government-run online retail.
In
other COVID related news, Lift & Co.
Corp. (TSXV:
LIFT) (OTCQB:
LFCOF), announced
today that it has temporarily laid off members of its
workforce and paused operations of non-profitable business segments due to
extenuating circumstances outside of the Company’s control.
Specifically, due to the COVID-19 pandemic and the
effects the pandemic is having on event businesses around the world, the
Company has made difficult and strategic decisions intended to preserve cash
and long-term shareholder value. The Company remains committed to continuing
its profitable Lift & Co. Expo and CannSell lines of business which will be
operationally unaffected by these changes.
“We are incredibly saddened by these necessary and
difficult actions. Our team members have been tirelessly dedicated to driving
shareholder value and building Cohesion and this pandemic and its impact on our
operations is a shock to us all,” said Matei Olaru, CEO of Lift & Co. “We
are doing everything possible to preserve jobs long term at Lift & Co as we
commit to preserving shareholder value and profitably servicing our valued
clients during these uncertain times.”
As the COVID-19 pandemic continues to grow and impact
commerce globally, Lift & Co. is focusing on ensuring the safety and
well-being of its employees and viability of the Company. The Company intends
to rehire those affected by the temporary layoffs if and when the COVID-19
pandemic is resolved.
Following
up from yesterday’s announcement regarding Cova
POS, now Greenline POS has
announced partnering with Dutchie.
"Cannabis
retailers now, more than ever, need online solutions to increase their
inventory visibility and add convenience to customers' ordering
experiences," said Albert Kim, CEO of Greenline POS. "We're proud to
be working with Dutchie to bring click and collect to Canada."
Online
menus are critical for cannabis retailers in a competitive landscape where
customers research online first before visiting stores. Understanding the
availability of a strain can make or break a decision to visit a store.
Click-and-collect
is an increasingly in-demand feature for stores that are competing on
convenience. It allows customers to reserve their orders online, and pick up in
store for a seamless purchasing experience.
"With
the emergence of click and collect in Canada, we are excited to integrate with
an innovative retail solution like Greenline," said Ross Lipson, CEO of
Dutchie. "With real-time menus and streamlined order fulfilment, the
Dutchie and Greenline integration offers a premium experience for both
consumers and retailers."
SparqOne, the
fastest-growing distribution company in California, announced
today it has entered into distribution agreements with
best-in-breed cannabis brands Kushy Punch, Church, Mindset Organics, Branded
and Smoakland to reach over 400 dispensaries statewide. SparqOne has rights to
distribute these throughout the state of California.
“We
are so pleased to welcome these exceptional companies and brands to our growing
portfolio, and now have a full vertical product line-up to meet every category
and pricing tier our dispensary partners offer,” said SparqOne General Manager
Andrew Dorsett. “We have built our company on three core tenets — superior
customer service, next day delivery, and real time sales and inventory
management.”
SparqOne
has distribution hubs in Los Angeles, Oakland, Orange County and Sacramento,
which provide the platform for its next-day delivery service to dispensaries
statewide. Every crew member goes through an extensive two-week training for compliance,
product knowledge and customer relations. In addition to Dorsett, a highly
decorated Marine Corps veteran, the team is comprised of a diverse group of
experts from the logistics, cannabis and biotech sectors including Marine and
Navy veterans, budtenders and cultivators.
Dorsett
added, “From Eureka to El Centro, Santa Barbara to Needles, we have strong
relationships with nearly every shop in the state. We work tirelessly with each
to improve their sales and profits through smart in-store education and product
positioning, frequent patient appreciation days, and bringing fresh, innovative
brands and products to their customers.
“You
will see our crew members sporting our distinctive S1 racing colors and apparel
with every delivery to reflect our ‘cannabis on demand’ service to shops and
customers throughout the state.”
CURE Pharmaceutical (OTC:CURR), an
innovative drug delivery and development company,
today announced the allowance of Chinese Patent No.
ZL201480039313.6. The new patent covers the loading of high amounts of active
drug on an oral thin film using its proprietary drug delivery systems,
including its lead drug product, CUREfilm Blue™, a soluble thin film for oral
administration of sildenafil citrate (Viagra™) to treat erectile dysfunction
(ED) in China.
“Securing
this key patent supports our global commercialization strategy for CUREfilm
Blue as well as follow-on drugs delivered using thin film,” said Rob Davidson,
CEO of CURE Pharmaceutical. “We are focused on the Asian market for this first
product, and in particular China, a high-demand ED drug market where consumers
are early adopters of innovative dosage forms.”
The
ED drug market is expected to reach USD $6.5 billion at a 6% compound annual
growth rate by 2025, according to QYResearch. The report points out that the
Asia Pacific market will be one of the fastest growing markets for ED medicine.
Sildenafil is leading the ED drug market worldwide with more than half of all
global sales.
The
new patent covers methods of preparing edible thin films that can deliver high
doses of active ingredients that are encapsulated using lipids to form micelles
or liposomes. This enables CURE to differentiate its oral thin film product
from sildenafil oral soluble films.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
#Coronavirus Innovation in #Biotech, #Hemp/ #Cannabis, #Tech Stocks (OTCQB: $SING), (OTCQX: $CRLBF), (NASDAQ: $GILD), (OTC: $CYDY), (NASDAQ: $ZM)
#Coronavirus Innovation in #Biotech, #Hemp/ #Cannabis,
#Tech Stocks (OTCQB: $SING), (OTCQX: $CRLBF), (NASDAQ: $GILD), (OTC: $CYDY), (NASDAQ: $ZM)
Entrepreneurism Thrives as
SinglePoint Inc. Launches USA Made Hemp
Seed Oil Infused Hand Sanitizer
Point Roberts WA, Delta, BC – March 17, 2020 - Investorideas.com, a leading investor news resource covering hemp/
cannabis stocks and coronavirus (COVID-19) stocks issues a snapshot looking at
the eruption of innovation in multiple sectors in the face of today’s ongoing pandemic.
Crisis has always incited innovation, creating winners and losers and this
pandemic is creating a global shift never before witnessed. Companies that are
agile enough to adapt and recognize the change can also seize opportunities by
providing a definite solution; which is what
SinglePoint Inc. (OTCQB: SING) is aiming to do by launching Klen Hands – Hand
Sanitizer with Moisturizing Hemp Seed Oil, made in the USA.
Read this news featuring
SING in full at https://www.investorideas.com/news/2020/biotech/03171CoronavirusInnovation.asp
On March 13th, Friday the 13th,
thought to be an unlucky day by some, SinglePoint Inc. (OTCQB: SING) boldly announced the launch
of Klen Hands, yet another example of
how they have consistently been on top of consumer and industry trends. Already
entrenched in the cannabis and cleantech sectors, during this current crisis, SinglePoint immediately saw the need for a crossover into the health
sector as shelves are being emptied of hand sanitizers.
According
to the press release: “Hand sanitizer is one of the most out of stock products there is in
most all retail locations. We do expect to sell out very quickly. As we move
into uncertain times, we have developed a product to directly combat the
coronavirus. Our hand sanitizer has 62% ethyl alcohol to keep hands klen
(clean) as well as hemp seed oil to keep hands soft and hydrated. Sanitize.
Hydrate. Repeat.”
Klen is currently being produced in SinglePoint's
Carlsbad facility and will ship directly to your location. Orders will be
fulfilled in the order they are received.
"We are working to develop solutions for both
product and technology in order to assist in the effort of combating COVID-19.
As many people know our company has deep ties to the Washington State area. We
believe we can provide solutions in the near term to help with the
dissemination of current, reliable information and in the interim use our
facilities to develop products such as hand sanitizer. We will be releasing
additional resources for individuals in the coming weeks." - Greg
Lambrecht CEO.
Another key trend arising in the cannabis space due
to the coronavirus outbreak, is the boom of cannabis delivery services. Cresco
Labs (CSE:CL)(OTCQX:CRLBF), one of the largest vertically integrated
multistate cannabis operators in the United States recently announced the launch of
a home delivery service for medical cannabis patients in the New Hartford area
of New York.
“Registered medical cannabis patients can place a
home delivery order seven days a week at Sunnyside. Shop with a minimum order
of $80 required for delivery service. Free delivery is available for orders of
$150 or more. Distributed from Cresco’s Sunnyside dispensary in New Hartford,
delivery services are available for patients in the following communities: New
Hartford, Utica, Marcy, Whitesboro, Oriskany, Clinton, Sauquoit, Frankfurt and
Rome.”
Sugarmade, Inc. (OTCQB:SGMD), along with the BudCars Cannabis Delivery Service, announced last week a sharp rise in demand for its cannabis delivery
service, driving an associated 10% week-over-week rise in total sales, over the
past two weeks. The Company believes this dynamic is being driven by the stay-at-home
trend that has emerged in many communities around the world in response to the
global pandemic outbreak of the COVID-19 disease.
It looks like there will also be a huge uptick in
cannabis sales as consumers are buying and hoarding cannabis just like toilet
paper and hand sanitizers.
“Retail stores across the United States have seen
an influx of traffic as Americans seek to stock up on basic supplies. Cannabis
retailers have seen a similar trend, with many consumers choosing to make fewer
trips to dispensaries, instead opting for larger, less frequent purchases as
COVID-19 fears grip the country,” reported a Motley Fool correspondent.
In the pharma and biotech sector we have seen
players from big to small announce potential solutions as they race to find a
vaccine for COVID-19. Gilead Sciences, Inc. (NASDAQ: GILD), a presumed leader, even by the WHO, announced late February the initiation of two Phase 3
clinical studies to evaluate the safety and efficacy of remdesivir in adults
diagnosed with COVID-19 (novel coronavirus). These randomized, open-label,
multicenter studies will enroll approximately 1,000 patients at medical centers
primarily across Asian countries, as well as other countries globally with high
numbers of diagnosed cases, beginning in March. The studies will assess two
dosing durations of remdesivir, administered intravenously. The initiation of
these studies follows the US Food and Drug Administration’s (FDA) rapid review
and acceptance of Gilead’s investigational new drug (IND) filing for remdesivir
for the treatment of COVID-19.
Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) announced Friday that it plans to evaluate its amniotic
fluid concentrate, AmnioBoost, in patients with acute respiratory distress
syndrome (ARDS) caused by coronavirus (COVID-19).
AmnioBoost has potential for use in the treatment
of ARDS, which is the principal cause of death in COVID-19 infection. Mortality
in COVID-19 infected patients with the inflammatory lung condition (ARDS) is
reported to approach 50%, and is associated with older age, co-morbidities such
as diabetes, higher disease severity, and elevated markers of inflammation.
Current therapeutic interventions do not appear to improve in-hospital
survival.
CytoDyn Inc. (OTC: CYDY), a
late-stage biotechnology company developing leronlimab (PRO 140), a CCR5
antagonist with the potential for multiple therapeutic indications, announced that the Company has submitted an investigational
new drug (IND) application to the US Food and Drug Administration (FDA) to
conduct a Phase 2 clinical trial with leronlimab (PRO 140) as a therapy for
patients who experience respiratory complications as a result of contracting
the coronavirus disease 2019 (COVID-19).
Looking at the tech sector, there are multitudes of
technology already in place that can be deployed and smart companies are
already on it. According to a report
from CNBC,
“Chinese technology giants are accelerating their efforts in the field of
health-care technology in areas from cloud computing to artificial intelligence
(AI) amid the new coronavirus outbreak. Alibaba (NYSE: BABA), Baidu (NASDAQ: BIDU), Tencent (OTC: TCEHY), Huawei and DiDi have all launched new health
tech features aimed at diagnosing cases and finding a vaccine for the
coronavirus.”
Drone technology is also being used for delivery
and mapping, and companies like Zoom Video Communications, Inc. (NASDAQ: ZM) are expected to see a boost from all the remote
workers.
As we self isolate, social distance and stock up,
let’s be smart as investors and not panic and really look at the bigger picture
unfolding; innovation and entrepreneurism at its best.
Visit
Investorideas.com cannabis and hemp stock directory
Visit
Investorideas.com biotech and coronavirus stocks directory https://www.investorideas.com/BIS/stock_list.asp
Visit
Investorideas.com tech stocks directory
About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source
publishing third party news, research and original financial content. Learn
about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s
original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: this article featuring SING is a paid
for services on Investorideas.co ( two thousand ) Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/
and tickertagstocknews.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Global
investors must adhere to regulations of each country. Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get free investor news alerts
Contact
Investorideas.com
800 665 0411
Monday 16 March 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 383 (TSX: $WEED.TO) (NYSE: $CGC)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 383 (TSX: $WEED.TO)
(NYSE: $CGC)
Delta, Kelowna, BC, March 16, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including marijuana
and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/03161WEED-CGC.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few company announcements.
But
first before getting into that, as the COVID-19 Pandemic has begun affecting
nearly every industry and especially the public markets, Investorideas will be
taking this opportunity to improve our content with more listeners staying at
home. That means we aim to bring you more interviews and in depth reports as well
as bring a more balanced focus on private and public companies.
If
you have any suggestions for potential interviewees or topics of discussion
please email me at taylor@investorideas.com
But
first, as governors and mayors across North
America order the shutdown of bars, restaurants, and gathering events, according to a recent article, cannabis stores are experiencing a dramatic surge in
sales that started over the weekend and now continues into the work week.
Retail cannabis
point-of-sale software company, Cova
Software today
announced a partnership with Dutchie to offer online ordering to cannabis customers for in-store
pickup or delivery, where permitted. This integration will expand revenue
streams allowing retailers to continue to provide a superior customer
experience while streamlining retail operations.
"Collaborating
with Dutchie not only helps retailers provide a more seamless online ordering
and delivery experience, but it also helps simplify complex store operations
like the order management process," said Cova CEO, Gary Cohen. "With
this new integration, consumers will receive their orders faster whether they
pick it up in-store or wait at home."
By integrating with
Dutchie, in addition to providing an alternate way to shop, Cova can help
clients maintain up-to-date inventory details, eliminate the need for manual
entry and fulfill online orders from the menu integration partner directly
within the Cova platform.
"At Dutchie,
we're passionate about bringing the dispensary shopping experience to the
comfort of the consumer's own home. That's why we must partner with robust
platforms like Cova," said Dutchie CEO, Ross Lipson. "Our integration
with Cova is fast and accurate, which translates to a smooth experience for
consumers and retailers."
As Dutchie expands
into new markets, it continues to be one of the best online ordering and
delivery solutions for dispensaries. In addition to providing robust inventory
management and seed-to-sale compliant POS, Cova offers open and secure
integrations to streamline operations and expand sales channels and tools.
Today, Tweed, a subsidiary of Canopy Growth Corporation (TSX:
WEED) (NYSE:
CGC)
announced
that
its first SKU, Tweed Houndstooth & Soda, began shipping to provincial
boards and retailers nationwide late last week.
When and where will
Tweed Ready-To-Drink cans be available for purchase?
Product shipments
began leaving Canopy Growth's Regional Distribution Centre on March 11, 2020.
Product availability on provincial eCommerce platforms and bricks-and-mortar
retail locations will vary depending on transportation timelines and provincial
distribution systems.
The company has developed
proprietary, industry-leading beverage technology to distill cannabis flower
into liquid which powers our Ready-To-Drink offerings. Each 355 mL can of
Tweed Houndstooth
& Soda contains 2mg of THC and <1mg CBD, combining Houndstooth Distilled
Cannabis™ with soda water and other ingredients for a refreshing cannabis
experience.
Muskoka Grown
Limited, a leading producer of high-quality craft
cannabis, announced that it
has successfully completed its first shipment to the Ontario Cannabis Store
("OCS"), marking its entrance into the Canadian recreational cannabis
market.
Muskoka
Grown has first launched with pre-rolls (2 x 0.5g packs), produced from
whole-flower high-quality dried cannabis. In the coming months, Muskoka Grown
will also be releasing strains in 3.5 gram flower format.
"Today's
shipment to the Ontario Cannabis Store marks a major milestone for Muskoka
Grown and we're extremely proud of everything we've been able to
accomplish," said David Grand, CEO & Founder, Muskoka Grown.
"We've taken our time with the creation of our state-of-the-art facility
and have been diligent in our phenotype selection process, to ensure our
product meets our high standards."
Looking
ahead, Muskoka Grown will continue to identify desirable strains to bring to
market through its full-scale laboratory and research & development room.
Muskoka Grown anticipates this will be the first of many craft cannabis orders
to come and are grateful for its partnership with the OCS. The Company is well
prepared to deliver on all of its supply agreements and looks forward to
continuing shipping products in Ontario.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and videos,
looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...